{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:20:18Z","timestamp":1783538418042,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MRC","award":["MR\/R006466\/1"],"award-info":[{"award-number":["MR\/R006466\/1"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["084286"],"award-info":[{"award-number":["084286"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.bmcl.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:49:27Z","timestamp":1549910967000},"page":"995-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Discovery and lead optimisation of a potent, selective and orally bioavailable RAR\u03b2 agonist for the potential treatment of nerve injury"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria B.","family":"Goncalves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher I.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barret Kalindjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carlstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.T.","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.02.011_b0005","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-3-642-58483-1_14","article-title":"Retinoids in neural development","author":"Maden","year":"1999"},{"key":"10.1016\/j.bmcl.2019.02.011_b0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1242\/jcs.113.14.2567","article-title":"The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia","volume":"113","author":"Corcoran","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmcl.2019.02.011_b0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nbd.2009.09.018","article-title":"A retinoic acid receptor \u03b2 agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord","volume":"37","author":"Agudo","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bmcl.2019.02.011_b0020","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bmc.2017.12.015","article-title":"Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist","volume":"26","author":"Clarke","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.011_b0025","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1021\/jm00119a021","article-title":"Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity","volume":"31","author":"Kagechika","year":"1988","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.011_b0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/intimm\/dxh066","article-title":"Prevention of acute and chronic allograft rejection by a novel retinoic acid receptor-\u03b1-selective agonist","volume":"16","author":"Seino","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.bmcl.2019.02.011_b0035","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/jpet.104.075598","article-title":"Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl) benzo [b] furan-2-yl]-1H-2-pyrrolyl} benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW) F1 mice","volume":"312","author":"Yamauchi","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2019.02.011_b0040","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/jm801532e","article-title":"Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor \u03b2 Ligands","volume":"52","author":"Lund","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.011_b0045","unstructured":"For ADME assays and Biological assays including bacterial cytotoxicity and genetic toxicity assays, see reference 4."},{"key":"10.1016\/j.bmcl.2019.02.011_b0050","unstructured":"Borthwick AD, Mills MT, Brown JT, Corcoran JPT, Goncalves MB, Kalindjian SB, 2016, PCT Patent Appl. WO 2016097004A1."},{"key":"10.1016\/j.bmcl.2019.02.011_b0055","doi-asserted-by":"crossref","first-page":"15731","DOI":"10.1523\/JNEUROSCI.1339-15.2015","article-title":"Neuronal RARbeta signaling modulates PTEN activity directly in neurons and via exosome transfer in astrocytes to prevent glial scar formation and induce spinal cord regeneration","volume":"35","author":"Goncalves","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2019.02.011_b0060","unstructured":"All animal studies were ethically reviewed and carried out in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 by the local veterinarian for the rat model of avulsion (see Ref. 11), and by CXR Biosciences Ltd, James Lindsay Place, Dundee Technopole, Dundee DD 5JJ, for the rat and dog PK (see Ref. 4)."}],"updated-by":[{"DOI":"10.1016\/j.bmcl.2019.05.058","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000}}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:28:05Z","timestamp":1760772485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0960894X19300873"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.011","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and lead optimisation of a potent, selective and orally bioavailable RAR\u03b2 agonist for the potential treatment of nerve injury","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}